Capricor Therapeutics's top three insider shareholders as of June 02, 2026 are Shinyaku Co Ltd Nippon (TenPercentOwner, 7.09Mn shares), Linda Marban (Chief Executive Officer, 211.10K shares), David B Musket (Director, 81.69K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| David B Musket | - | 81,692 | 0 | 09 Aug, 2024 |
| Shinyaku Co Ltd Nippon | - | 7,090,351 | 0 | 24 Sep, 2024 |
| Linda Marban | Chief Executive Officer | 211,104 | 0 | 05 Mar, 2025 |
| Karen Krasney | Evp, General Counsel | 30,547 | 0 | 01 Apr, 2026 |
| Anthony Bergmann | Chief Financial Officer | 8,223 | 0 | 01 Apr, 2026 |
| Louis Manzo | - | 62,147 | 0 | 23 Feb, 2023 |
| Paul Gisbert Auwaerter | - | 5,000 | 0 | 10 Oct, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Apr, 2026 | Karimah Es Sabar | Common Stock | A | 7,529 | $3.18 | 7,529 | D | M |
| 02 Apr, 2026 | Karimah Es Sabar | Common Stock | A | 7,529 | $3.18 | 7,529 | D | M |
| 02 Apr, 2026 | Karimah Es Sabar | Common Stock | D | 7,529 | $32.00 | 0 | D | S |
| 02 Apr, 2026 | Karimah Es Sabar | Common Stock | D | 7,529 | $32.00 | 0 | D | S |
| 02 Apr, 2026 | Karimah Es Sabar | Stock Option (Right to Buy) | D | 7,529 | $0.00 | 161 | D | M |
| 02 Apr, 2026 | Karimah Es Sabar | Stock Option (Right to Buy) | D | 7,529 | $0.00 | 161 | D | M |
| 31 Mar, 2026 | Karimah Es Sabar | Common Stock | A | 61,265 | $4.86 | 61,265 | D | M |
| 31 Mar, 2026 | Anthony Bergmann | Common Stock | A | 25,000 | $3.18 | 33,223 | D | M |
| 31 Mar, 2026 | Karen Krasney | Common Stock | A | 693 | $1.39 | 31,240 | D | M |
| 31 Mar, 2026 | Karimah Es Sabar | Common Stock | A | 61,265 | $4.86 | 61,265 | D | M |
| 31 Mar, 2026 | Karen Krasney | Common Stock | A | 693 | $1.39 | 31,240 | D | M |
| 31 Mar, 2026 | Karimah Es Sabar | Common Stock | D | 61,265 | $30.17 | 0 | D | S |
| 31 Mar, 2026 | Anthony Bergmann | Common Stock | D | 25,000 | $30.13 | 8,223 | D | S |
| 31 Mar, 2026 | Karimah Es Sabar | Common Stock | D | 61,265 | $30.17 | 0 | D | S |
| 31 Mar, 2026 | Karen Krasney | Common Stock | A | 21,488 | $3.74 | 52,728 | D | M |
| 31 Mar, 2026 | Karen Krasney | Common Stock | A | 21,488 | $3.74 | 52,728 | D | M |
| 01 Apr, 2026 | Karimah Es Sabar | Common Stock | A | 53,735 | $4.86 | 53,735 | D | M |
| 31 Mar, 2026 | Anthony Bergmann | Stock Option (Right to Buy) | D | 25,000 | $0.00 | 141,980 | D | M |
| 31 Mar, 2026 | Karen Krasney | Common Stock | A | 2,819 | $3.18 | 55,547 | D | M |
| 31 Mar, 2026 | Karen Krasney | Common Stock | A | 2,819 | $3.18 | 55,547 | D | M |